Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
President Xi on global, regional security
Editor's note:Two years ago, at the opening ceremony of the Boao Forum for Asia (BFA) Annual Confere2024-04-30Xizang commemorates 65th anniversary of democratic reform that ended feudal serfdom
People visit the Potala Palace square in Lhasa, southwest China's Xizang Autonomous Region, Feb.2024-04-30St. Petersburg tightens security measures after Moscow terrorist attack
Security measures have been tightened in St. Petersburg after a terrorist attack at the Crocus City2024-04-30Israel artist refuses to open Israel pavilion at Venice Biennale
VENICE, Italy (AP) — The artist and curators representing Israel at this year’s Venice Biennale anno2024-04-30Overseas Chinese history museum opens new branch in S. China
The Overseas Chinese History Museum of China has opened a new branch in the city of Chaozhou in sout2024-04-30China launches new remote sensing satellite
A Long March-2D carrier rocket carrying the Yaogan-42 01 satellite blasts off from the Xichang Satel2024-04-30
atest comment